Healthcare / Pharmaceutical RetailersUpdated 2026-05-10 22:07 UTC

BVMF/DMVF3 stock hub

BVMF/DMVF3 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BVMF/DMVF3is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

341.6M

Brazil Stock Exchange

Market data

Price

Recent price action with selectable time range.

BVMF/DMVF3BVMF/DMVF3

—

Loading chart…

In the news

Latest news · BVMF/DMVF3

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E14.3

P25 n/aP50 n/aP75 n/a

ROE2.6

P25 n/aP50 n/aP75 n/a

ROIC6.1

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BVMF/DMVF3 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

204

Groups with data

Currency

BRL

Showing 204 of 204 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Brazil
Country code	BR
Employees	4,500
Employees Change	500%
Employees Change Percent	12.5
Enterprise value	BRL 853.6M
Exchange	Brazil Stock Exchange
Financial currency	BRL
First seen	2026-05-10
Industry	Pharmaceutical Retailers
Isin	BRDMVFACNOR9
Last refreshed	2026-05-10
Market cap	BRL 341.6M
Price	BRL 6.75
Price currency	BRL
Rev Per Employee	613,073.33x
Sector	Healthcare
Sic	5912
Symbol	bvmf/DMVF3
Website	https://www.d1000varejofarma.com.br/ri

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	7.01%
EV Earnings	35.64x
EV/EBIT	9.66x
EV/EBITDA	3.8x
EV/FCF	9.29x
EV/Sales	0.31x
FCF yield	26.9%
P/B ratio	0.37x
P/E ratio	14.26x
P/S ratio	0.12x
PE Ratio3 Y	13.7x
PE Ratio5 Y	26.39x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	3.2%
EBITDA Margin	4.88%
FCF margin	3.33%
Gross margin	28.8%
Gross Profit	BRL 794.5M
Gross Profit Growth	15.21%
Gross Profit Growth Q	18.16%
Gross Profit Growth3 Y	17.03%
Gross Profit Growth5 Y	18.6%
Net Income	BRL 23.9M
Net Income Growth	-12.73%
Net Income Growth Q	168.74%
Net Income Growth3 Y	25.72%
Net Income Growth5 Y	183.6%
Pretax Margin	0.73%
Profit Margin	0.87%
Profit Per Employee	BRL 5,322
ROA	2.9
Roa5y	1.73
ROCE	6.34
ROE	2.64
Roe5y	1.9
ROIC	6.12
Roic5y	3.56

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	25.48%
Cagr3y	25.31%
Cagr5y	-7.36%
EPS Growth	-12.73
EPS Growth Q	168.7
EPS Growth3 Y	25.72
EPS Growth5 Y	183.6
FCF Growth	-12.6%
FCF Growth Q	16.63%
FCF Growth3 Y	8.31%
OCF Growth	-6.52%
OCF Growth Q	0.33%
OCF Growth3 Y	17.21%
OCF Growth5 Y	95.37%
Revenue Growth	23.42x
Revenue Growth Q	11.13x
Revenue Growth3 Y	21.6x
Revenue Growth5 Y	21.57x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	BRL 1.45
Assets	BRL 2B
Cash	BRL 23M
Current Assets	BRL 620.3M
Current Liabilities	BRL 573.4M
Debt	BRL 535M
Debt EBITDA	BRL 2.38
Debt Equity	BRL 0.58
Debt FCF	BRL 5.82
Equity	BRL 920.8M
Interest Coverage	1.35
Liabilities	BRL 1.1B
Long Term Assets	BRL 1.4B
Long Term Liabilities	BRL 484.6M
Net Cash	BRL -512M
Net Cash By Market Cap	BRL -150
Net Debt EBITDA	BRL 3.81
Net Debt Equity	BRL 0.56
Net Debt FCF	BRL 5.57
Tangible Book Value	BRL 314.1M
Tangible Book Value Per Share	BRL 6.21
WACC	7.72

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.06
Inventory Turnover	6.85
Net Working Capital	BRL 159.4M
Quick ratio	0.47
Working Capital	BRL 33.3M
Working Capital Turnover	BRL 45.68

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	25.47%
200-day SMA	5.79
3Y total return	96.79%
50-day SMA	6.79
50-day SMA vs 200-day SMA	50over200
5Y total return	-31.75%
All Time High	16.75
All Time High Change	-59.7%
All Time High Date	2020-08-10
All Time Low	3.18
All Time Low Change	112.26%
All Time Low Date	2023-03-23
ATR	0.26
Beta	0.08
Beta1y	0.45
Beta2y	0.43
Ch YTD	-2.17
High	6.84
High52	7.5
High52 Date	2026-02-27
High52ch	-10%
Low	6.74
Low52	4.28
Low52 Date	2025-09-12
Low52ch	57.71%
Ma50ch	-0.52%
Price vs 200-day SMA	16.68%
RSI	47.4
RSI Monthly	54.98
RSI Weekly	55.53
Sharpe ratio	0.59x
Sortino ratio	1.07
Tr YTD	-2.17
Tr1m	-0.74%
Tr3m	-0.88%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	BRL 88.3M
Operating Income Growth	32.67
Operating Income Growth Q	142.2
Operating Income Growth3 Y	33.03
Operating Income Growth5 Y	66.04
Operating margin	3.2

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	13,426,759%
Net Borrowing	-35,928,000
Shares Institutions	1.12%
Shares Out	50,602,842
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	BRL 91.9M
Average Volume	102,565x
Bv Per Share	18.2
CAPEX	BRL -78.6M
Ch1m	-0.74
Ch1y	25.47
Ch3m	-0.88
Ch3y	96.79
Ch5y	-31.75
Ch6m	39.18
Change	-2.6%
Change From Open	-0.3
Close	6.93
Days Gap	-2.31
Depreciation Amortization	43,893,000
Dollar Volume	707,400
Earnings Date	2026-05-13
EBIT	BRL 88.3M
EBITDA	BRL 134.5M
EPS	BRL 0.47
F Score	6
FCF	BRL 91.9M
FCF EV Yield	10.76x
FCF Per Share	BRL 1.82
Financing CF	-85,370,000
Fiscal Year End	December
Founded	2,010
Goodwill	436,251,000
Graham Number	13.92
Graham Upside	106.2
Income Tax	BRL -3.7M
Investing CF	-94,835,000
Is Primary Listing	1
Last Earnings Date	2025-10-31
Last Report Date	2025-12-31
Lynch Fair Value	BRL 11.83
Lynch Upside	75.29
Ma150	6.16
Ma150ch	9.52%
Ma20	6.88
Ma20ch	-1.92%
Net CF	-9,755,000
Next Earnings Date	2026-05-13
Open	6.77
P FCF Ratio	3.72
P OCF Ratio	2
Position In Range	10
Ppne	567,989,000
Price Date	2026-05-08
Price EBITDA	BRL 2.54
Ptbv Ratio	1.09
Relative Volume	1.02x
Revenue	2,758,830,000x
Tax By Revenue	-0.13x
Tr6m	39.18%
Volume	104,800

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does BVMF/DMVF3 pay a dividend?

Capital-return profile for this ticker.

Performance

BVMF/DMVF3 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BVMF/DMVF3?

Insider, institutional, and short-interest positioning.

Institutional ownership

+1.1%

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

BVMF/DMVF3 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

47.4

Neutral momentum band

Price vs 200-day MA

+16.7%

50/200-day relationship not available

Beta (5Y)

0.08

Less volatile than the market

Sharpe ratio

0.59

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BVMF/DMVF3

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bvmf/DMVF3 stock rating?

bvmf/DMVF3 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bvmf/DMVF3 analysis?

The full report lives at /stocks/bvmf/DMVF3/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bvmf/DMVF3?

The latest report frames bvmf/DMVF3 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bvmf/DMVF3 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.